D. Barboriak

发表

Dynamic contrast enhanced-MRI in head and neck cancer patients: Variability of the precontrast longitudinal relaxation time (T10).

J. MacFall, O. Craciunescu, D. Brizel, 2010, Medical physics.

Dynamic contrast enhanced-MRI in head and neck cancer patients: variability of the precontrast longitudinal relaxation time (T10).

J. MacFall, O. Craciunescu, D. Brizel, 2010, Medical physics.

Imaging of brain tumors with diffusion-weighted and diffusion tensor MR imaging.

Daniel P Barboriak, D. Barboriak, 2003, Magnetic resonance imaging clinics of North America.

Metrology Standards for Quantitative Imaging Biomarkers.

Erich P Huang, N. Obuchowski, R. Wahl, 2015, Radiology.

Metrology standards for Quantitative imaging Biomarkers 1

Erich P Huang, N. Obuchowski, R. Wahl, 2015 .

Noncompartmental kinetic analysis of DCE‐MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab

N. van Bruggen, D. Barboriak, R. Port, 2010, Magnetic resonance in medicine.

Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme

D. Barboriak, H. Friedman, A. Desjardins, 2009, Journal of magnetic resonance imaging : JMRI.

Artificial Intelligence in Neuroradiology: Current Status and Future Directions

Y. Lui, M. Wintermark, G. Zaharchuk, 2020, American Journal of Neuroradiology.

ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

D. Mankoff, Lucy Hanna, A. Sorensen, 2016, Clinical Cancer Research.

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM).

Raymond Y Huang, P. Brown, P. Wen, 2020, Neuro-oncology.

Chemodosimetry of in vivo tumor liposomal drug concentration using MRI

M. Dewhirst, J. MacFall, Daohai Yu, 2006 .

Comparison of three physiologically‐based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging

J. MacFall, D. Barboriak, B. Viglianti, 2008, Journal of magnetic resonance imaging : JMRI.

Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.

R. Coleman, J. Provenzale, D. Barboriak, 2003, Radiology.

Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers

Andrew L Beers, David A. Hormuth II, R. Stafford, 2018, Scientific Data.

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.

Daniel P Barboriak, James M Provenzale, Srinivasan Mukundan, 2006, Radiology.

Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims.

Nicholas Petrick, Paul Kinahan, Nancy A Obuchowski, 2016, Academic radiology.

Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.

M. Gilbert, J. Boxerman, R. McKinstry, 2019, Radiology.

RIDER (Reference Database to Evaluate Response) Committee Combined Report, 9/25/2008 Sponsored by NIH, NCI, CIP, ITDB Causes of and Methods for Estimating/Ameliorating Variance in the Evaluation of Tumor Change in Response to Therapy

Geoffrey McLennan, Reinhard Beichel, Luc Bidaut, 2008 .

CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke.

Reto Meuli, Ting-Yim Lee, Max Wintermark, 2002, Radiology.

Repeatability of quantitative metrics derived from MR diffusion tractography in paediatric patients with epilepsy.

D. Barboriak, M. Paldino, K. Hedges, 2014, The British journal of radiology.

Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.

M. Gilbert, A. Sorensen, J. Boxerman, 2013, Neuro-oncology.

Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma

M. Gilbert, A. Sorensen, J. Boxerman, 2015, International journal of oncology.

Response assessment criteria for brain metastases: proposal from the RANO group.

Martin Bendszus, Riccardo Soffietti, Susan M. Chang, 2015, The Lancet. Oncology.

Response to Letter to Editor.

Raymond Y Huang, P. Brown, P. Wen, 2020, Neuro-oncology.

Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas.

Leland S. Hu, Susan M. Chang, B. Rosen, 2020, Neuro-oncology.

Quantitative Imaging to Assess Tumor Response to Therapy: Common Themes of Measurement, Truth Data & Error Sources | NIST

G. McLennan, S. Armato, Paul Kinahan, 2009 .

Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets.

Huiman X Barnhart, Daniel P Barboriak, H. Barnhart, 2009, Translational oncology.

Value of Dynamic Contrast Perfusion MRI to Predict Early Response to Bevacizumab in Newly Diagnosed Glioblastoma: Results from ACRIN 6686 Multi-Center Trial.

J. Boxerman, K. Schmainda, D. Barboriak, 2020, Neuro-oncology.

MR arteriography of intracranial circulation.

J. Provenzale, D. Barboriak, 1998, AJR. American journal of roentgenology.

Evaluation of software for registration of contrast-enhanced brain MR images in patients with glioblastoma multiforme.

J. Provenzale, D. Barboriak, 2002, AJR. American journal of roentgenology.

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

Albert Lai, Soonmee Cha, Rajan Jain, 2012, Journal of Neuro-Oncology.

Limbic encephalitis: comparison of FDG PET and MR imaging findings.

J. Provenzale, R. Coleman, D. Barboriak, 1998, AJR. American journal of roentgenology.

Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.

J. Bowsher, K. Greer, R. Coleman, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of bevacizumab (BEV) and irinotecan (CPT-11) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in glioblastoma (GBM) patients

D. Barboriak, H. Friedman, D. Reardon, 2008 .

Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.

D. Barboriak, H. Friedman, D. Reardon, 2011, The British journal of radiology.

J. Provenzale, J. Taveras, D. Barboriak, 1995, Journal of computer assisted tomography.

Patients with antiphospholipid antibodies: CT and MR findings of the brain.

J. Provenzale, D. Barboriak, T. Ortel, 1996, AJR. American journal of roentgenology.

Drinking patterns and preferences among heart patients.

D. Barboriak, J. Barboriak, A. Anderson, 1981, Currents in alcoholism.

Dural sinus thrombosis associated with activated protein C resistance: MR imaging findings and proband identification.

J. Provenzale, D. Barboriak, T. Ortel, 1998, AJR. American journal of roentgenology.

Brain infarction in young adults: etiology and imaging findings.

J. Provenzale, D. Barboriak, 1997, AJR. American journal of roentgenology.

Antiphospholipid antibodies: findings at arteriography.

J. Provenzale, D. Barboriak, T. Ortel, 1998, AJNR. American journal of neuroradiology.

Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.

Daniel P Barboriak, Edward F Jackson, L. Bidaut, 2009, Translational oncology.

Risk factors in patients undergoing a second aorta-coronary bypass procedure.

F. Tristani, D. Barboriak, A. Rimm, 1978, The Journal of thoracic and cardiovascular surgery.

Fundamentals of quantitative dynamic contrast-enhanced MR imaging.

Michael J Paldino, Daniel P Barboriak, D. Barboriak, 2009, Magnetic resonance imaging clinics of North America.

Gliosarcoma Metastatic to the Leptomeninges and Dura

D. Barboriak, B. Mansouri, R. Kilani, 2013, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

White matter lesion contrast in fast spin-echo fluid-attenuated inversion recovery imaging: effect of varying effective echo time and echo train length.

J. MacFall, J. Provenzale, D. Barboriak, 1999, AJR. American journal of roentgenology.

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.

J. Boxerman, K. Schmainda, D. Barboriak, 2015, Neuro-oncology.

Serial MR imaging of pineal cysts: implications for natural history and follow-up.

J. Provenzale, D. Barboriak, L. Lee, 2001, AJR. American journal of roentgenology.

Pictorial review: magnetic resonance angiography of arterial variants at the Circle of Willis.

J. Provenzale, D. Barboriak, 1997, Clinical radiology.

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.

Marion Smits, Bradley J Erickson, Jayashree Kalpathy-Cramer, 2015, Neuro-oncology.

Creation of DICOM—Aware Applications Using ImageJ

Gerald E. York, James R. MacFall, Daniel P. Barboriak, 2005, Journal of Digital Imaging.

Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.

A Gregory Sorensen, Rajan Jain, Daniel P Barboriak, 2013, Neuro-oncology.

Pediatric Giant Prolactinoma Presenting With Acute Obstructive Hydrocephalus and Intracranial Hypertension

D. Barboriak, Nancie J. MacIver, H. Fuchs, 2021, Journal of the Endocrine Society.

Ruptured Maxillary Retention Cyst: Cause of Unilateral Rhinorrhea after Trauma

D. Barboriak, J. Hoang, E. C. Smith, 2009, American Journal of Neuroradiology.

Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans

A. Friedman, D. Bigner, M. Brady, 2011, Neurosurgery.

J. Provenzale, D. Barboriak, R. Robertson, 1994, AJNR. American journal of neuroradiology.

Candidal splenic abscesses.

D. Barboriak, F. S. Chew, P. Smith, 1991, AJR. American journal of roentgenology.

Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial

J. Boxerman, K. Schmainda, D. Barboriak, 2019, American Journal of Neuroradiology.

Do prolonged febrile seizures produce medial temporal sclerosis? Hypotheses, MRI evidence and unanswered questions.

J. MacFall, J. Provenzale, T. Mitchell, 2002, Progress in brain research.

Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons

Kyle J Myers, Huiman X Barnhart, Paul E Kinahan, 2014, Statistical methods in medical research.

Trichothiodystrophy with Dysmyelination and Central Osteosclerosis

D. Barboriak, N. Prose, J. Harreld, 2010, American Journal of Neuroradiology.

Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke.

Ting-Yim Lee, Max Wintermark, Michael H Lev, 2003, AJNR. American journal of neuroradiology.

An automated method for nonparametric kinetic analysis of clinical DCE‐MRI data: Application to glioblastoma treated with bevacizumab

Daniel P. Barboriak, Gregory Z. Ferl, Lu Xu, 2010, Magnetic resonance in medicine.

Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease.

J. Provenzale, D. Barboriak, K. Sims, 1995, AJNR. American journal of neuroradiology.

MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia.

J. Provenzale, D. Barboriak, O. Boyko, 1994, AJR. American journal of roentgenology.

Comparison of patient age with MR imaging features of gangliogliomas.

D. DeLong, R. McLendon, J. Provenzale, 2000, AJR. American journal of roentgenology.

Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

J. Petrella, J. Provenzale, D. Barboriak, 2001, AJNR. American journal of neuroradiology.

Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis.

James R. MacFall, James M. Provenzale, Daniel P. Barboriak, 2008, AJR. American journal of roentgenology.

A fully automatic extraction of magnetic resonance image features in glioblastoma patients.

Maciej A Mazurowski, Daniel P Barboriak, Jing Zhang, 2014, Medical physics.

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

D. Mankoff, Lucy Hanna, K. Schmainda, 2018, PloS one.

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686

M. Gilbert, A. Sorensen, J. Boxerman, 2018, Neuro-oncology.

Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma

J. Kalpathy-Cramer, Jayashree Kalpathy-Cramer, S. Stufflebeam, 2015, American Journal of Neuroradiology.

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

A Gregory Sorensen, Kathleen M Schmainda, Daniel P Barboriak, 2015, Neuro-oncology.

Sacral neurofibroma.

D. Barboriak, F. S. Chew, S. Rivitz, 1992, AJR. American journal of roentgenology.

Vertex epidural hematomas: imaging findings and diagnostic pitfalls.

J. Provenzale, D. Barboriak, O. Harbury, 2000, European journal of radiology.

Assessment of apparent diffusion coefficient in normal and degenerated intervertebral lumbar disks: initial experience.

D. DeLong, J. Eastwood, J. Provenzale, 2005, Radiology.

MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex

K. Krishnan, J. MacFall, D. Barboriak, 2002, Psychiatry Research: Neuroimaging.

Learning and recall in subjects at genetic risk for Alzheimer's disease.

P. Doraiswamy, S. Tabrizi, D. Barboriak, 2002, The Journal of neuropsychiatry and clinical neurosciences.

Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources.

Nicholas Petrick, Paul E Kinahan, Marios A Gavrielides, 2009, Translational oncology.

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.

D. Barboriak, H. Friedman, A. Desjardins, 2012, The British journal of radiology.

A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations

Thomas E. Yankeelov, Wei Huang, Catherine Coolens, 2017, Scientific Reports.

Repeatability of Automated Image Segmentation with BraTumIA in Patients with Recurrent Glioblastoma

D. Barboriak, A. Desjardins, J. Vredenburgh, 2021, American Journal of Neuroradiology.

Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.

Naira Muradyan, Daniel P Barboriak, James R MacFall, 2012, International journal of radiation oncology, biology, physics.

Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625

J. Boxerman, K. Schmainda, D. Barboriak, 2023, Frontiers in Oncology.

Magnetic resonance spectroscopy in Alzheimer's disease: focus on N‐acetylaspartate

P. Doraiswamy, D. Barboriak, H. Charles, 2000, Acta neurologica Scandinavica. Supplementum.

Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls.

J. Provenzale, D. Barboriak, G. Joseph, 1998, AJR. American journal of roentgenology.

Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.

E. Merkle, D. Barboriak, B. Dale, 2007, Academic radiology.

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

T. Mikkelsen, M. Prados, P. Wen, 2012, Journal of Neuro-Oncology.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

M. J. van den Bent, T. Cloughesy, L. Shankar, 2023, Journal of Clinical Oncology.

Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma

Jayashree Kalpathy-Cramer, S. Stufflebeam, K. Schmainda, 2015, American Journal of Neuroradiology.

Chemodosimetry of in vivo tumor liposomal drug concentration using MRI.

M. Dewhirst, J. MacFall, Daohai Yu, 2006, Magnetic resonance in medicine.

Response assessment criteria for brain metastases: proposal from the RANO group.

Susan M. Chang, P. Brown, M. Mehta, 2015, The Lancet. Oncology.

Hippocampal sulcal cavities on MRI: Relationship to age and apolipoprotein E genotype

H C Charles, P. Doraiswamy, D. Barboriak, 2000, Neurology.

ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using FMISO PET and MRI.

D. Mankoff, Lucy Hanna, K. Schmainda, 2015 .

with Recurrent Glioblastoma Segmentation with BraTumIA in Patients Repeatability of Automated Image

D. Barboriak, J. Vredenburgh, N. A. Khalaf, 2022 .

Association of internal carotid artery injury with carotid canal fractures in patients with head trauma.

D. DeLong, J. Petrella, J. Provenzale, 2005, AJR. American journal of roentgenology.